411 related articles for article (PubMed ID: 17058135)
1. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
Chernov MF; Hayashi M; Izawa M; Ono Y; Hori T
Int J Clin Oncol; 2006 Oct; 11(5):375-84. PubMed ID: 17058135
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
3. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.
Chernov MF; Nakaya K; Kasuya H; Kato K; Ono Y; Yoshida S; Nakamura R; Suzuki T; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
J Neurol Sci; 2009 Sep; 284(1-2):168-74. PubMed ID: 19497588
[TBL] [Abstract][Full Text] [Related]
4. Early metabolic changes in metastatic brain tumors after Gamma Knife radiosurgery: 1H-MRS study.
Chernov MF; Hayashi M; Izawa M; Abe K; Usukura M; Ono Y; Kubo O; Hori T
Brain Tumor Pathol; 2004; 21(2):63-7. PubMed ID: 15700835
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of proton magnetic resonance spectroscopy for differential diagnosis of pediatric posterior fossa tumors].
Zakrzewski K; Kreisel J; Polis L; Nowosławska E; Liberski PP; Biegański T
Neurol Neurochir Pol; 2001; 35 Suppl 5():19-25. PubMed ID: 11935675
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.
Ishimaru H; Morikawa M; Iwanaga S; Kaminogo M; Ochi M; Hayashi K
Eur Radiol; 2001; 11(9):1784-91. PubMed ID: 11511902
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin.
Chernov MF; Ono Y; Kubo O; Hori T
Brain Tumor Pathol; 2006 Apr; 23(1):35-40. PubMed ID: 18095117
[TBL] [Abstract][Full Text] [Related]
8. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
[TBL] [Abstract][Full Text] [Related]
9. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
Caivano R; Lotumolo A; Rabasco P; Zandolino A; D'Antuono F; Villonio A; Lancellotti MI; Macarini L; Cammarota A
Int J Neurosci; 2013 Aug; 123(8):537-43. PubMed ID: 23390934
[TBL] [Abstract][Full Text] [Related]
10. Proton MRS of the peritumoral brain.
Chernov MF; Kubo O; Hayashi M; Izawa M; Maruyama T; Usukura M; Ono Y; Hori T; Takakura K
J Neurol Sci; 2005 Feb; 228(2):137-42. PubMed ID: 15694194
[TBL] [Abstract][Full Text] [Related]
11. Possible role of single-voxel (1)H-MRS in differential diagnosis of suprasellar tumors.
Chernov MF; Kawamata T; Amano K; Ono Y; Suzuki T; Nakamura R; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
J Neurooncol; 2009 Jan; 91(2):191-8. PubMed ID: 18825316
[TBL] [Abstract][Full Text] [Related]
12. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
13. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy.
Estève F; Rubin C; Grand S; Kolodié H; Le Bas JF
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):279-86. PubMed ID: 9457810
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
15. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
16. MR spectroscopic evaluation of brain tissue damage after treatment for pediatric brain tumors.
Blamek S; Larysz D; Ficek K; Sokół M; Miszczyk L; Tarnawski R
Acta Neurochir Suppl; 2010; 106():183-6. PubMed ID: 19812945
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy of brain-stem lesions.
Smith JK; Londono A; Castillo M; Kwock L
Neuroradiology; 2002 Oct; 44(10):825-9. PubMed ID: 12389131
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopic evaluation of brain tissue metabolism after irradiation for pediatric brain tumors in long-term survivors: a report of two cases.
Blamek S; Wydmański J; Sokół M; Matulewicz L; Boguszewicz L
Acta Neurochir Suppl; 2010; 106():191-4. PubMed ID: 19812947
[TBL] [Abstract][Full Text] [Related]
20. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
